Serotype incidence and antibiotic susceptibility of Streptococcus pneumoniae causing invasive disease in Scotland, 1999–2002
Open Access
- 1 April 2005
- journal article
- research article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 54 (4) , 327-331
- https://doi.org/10.1099/jmm.0.45718-0
Abstract
Pneumococcal disease remains an important cause of invasive and non-invasive disease in Scotland and elsewhere. The Scottish Meningococcus and Pneumococcus Reference Laboratory receives isolates of Streptococcus pneumoniae from diagnostic laboratories around Scotland. Here, the serogroups/types and antibiotic-susceptibility patterns of invasive isolates received between 1999 and 2002 are described. There were a total of 1741 invasive isolates received, the most common serogroups/types being 14 (19.8 %), 9 (10.2 %), 6 (8.3 %), 19 (7.9 %), 23 (7.9 %), 4 (6.5 %), 8 (6.4 %), 3 (5.7 %), 1 (3.8 %), 7 (3.8 %) and 18 (3.4 %). Importantly, serotypes 7 and 8 are not represented in the 7-, 9- and 11-valent pneumococcal conjugate polysaccharide vaccines. There were 67 (3.8 %) isolates considered penicillin non-susceptible, although no penicillin resistance (MIC ⩾ 0.002 mg ml−1) was recorded. One hundred and ninety-four (11.1 %) isolates, predominantly of serotype 14, were resistant to erythromycin, and 12 (0.7 %) were resistant to ciprofloxacin. This information provides an important dataset that will prove essential prior to and during the implementation of pneumococcal conjugate vaccines in the UK.Keywords
This publication has 11 references indexed in Scilit:
- Invasive Pneumococcal Disease in Scotland, 1999-2001: Use of Record Linkage to Explore Associations between Patients and Disease in Relation to Future Vaccination PolicyClinical Infectious Diseases, 2003
- Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the NetherlandsClinical Therapeutics, 2003
- Clonal Distribution of Invasive Pneumococcal Isolatesfrom Children and Selected Adults in the United States Prior to7-Valent Conjugate VaccineIntroductionJournal of Clinical Microbiology, 2003
- Genetic Relatedness, Antibiotic Susceptibility, and Serotype Distribution ofStreptococcus pneumoniaeResponsible for Meningitis in Poland, 1997-2001Microbial Drug Resistance, 2003
- Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate VaccineNew England Journal of Medicine, 2003
- Nationwide Surveillance of NasopharyngealStreptococcus pneumoniaeIsolates from Children with Respiratory Infection, Switzerland, 1998–1999The Journal of Infectious Diseases, 2003
- The pneumococcus: carriage, disease and conjugate vaccinesJournal of Medical Microbiology, 2002
- Prevalence of Penicillin Non-susceptible Invasive Pneumococcal Disease in the Elderly in Scotland, 1992-99Scandinavian Journal of Infectious Diseases, 2002
- Pneumococcal disease in childhoodHospital Medicine, 2001
- Serotypes/groups distribution and antimicrobial resistance of invasive pneumococcal isolates: implications for vaccine strategiesEpidemiology and Infection, 2000